Novo Nordisk A/S Class B
No trades
No trades
Corporate debt securities
Below is the list of Novo Nordisk A/S Class B bonds, sorted by yield to worst. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Symbol | YTW % | Price % | Coupon % | Maturity date | Outstanding amt | Face value | S&P rating | Fitch rating | Issuer |
|---|---|---|---|---|---|---|---|---|---|
| 4.48% | 93.63% | 4.000% | 2045-11-20 | 750 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 4.09% | 95.59% | 3.625% | 2038-02-20 | 750 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 4.02% | 96.37% | 3.625% | 2037-05-27 | 1.25 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.87% | 96.43% | 3.375% | 2035-02-20 | 600 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.80% | 97.18% | 3.375% | 2034-05-21 | 1.35 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.67% | 96.71% | 3.125% | 2033-05-27 | 900 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.58% | 97.06% | 3.000% | 2032-02-20 | 600 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.47% | 99.10% | 3.250% | 2031-01-21 | 1 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.38% | 97.82% | 2.875% | 2030-08-27 | 1 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.24% | 93.71% | 1.375% | 2030-03-31 | 500 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.21% | 99.78% | 3.125% | 2029-01-21 | 1 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.21% | 98.28% | 2.500% | 2029-02-20 | 650 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.15% | 98.33% | 2.375% | 2028-05-27 | 1.45 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 3.12% | 94.86% | 0.125% | 2028-06-04 | 650 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 2.90% | 98.08% | 1.125% | 2027-09-30 | 500 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| 1.61% | 100.25% | 1.633% | 2041-06-11 | 175 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S | |
| 1.28% | 100.03% | 1.315% | 2036-06-11 | 335 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S | |
| 0.95% | 99.54% | 0.943% | 2032-06-11 | 400 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S | |
| 0.56% | 99.95% | 0.575% | 2029-06-11 | 180 M CHF | 100,000.00 CHF | AA | — | Novo Nordisk A/S | |
| — | 99.89% | 2.419% | 2027-11-20 | 650 M EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV | |
| — | 99.66% | 2.504% | 2027-05-27 | 1.4 B EUR | 1,000.00 EUR | AA | — | Novo Nordisk Finance (Netherlands) BV |